Moreover, pSer147-YAP shielded ovarian cancer cells against Taxol and cisplatin treatment, and in ovarian cancer patients there was an association between nuclear sequestration of the protein and reduced progression free survival (PFS) [42]. This evidence concerns the gene YAP1 and ovarian carcinoma.